CHINA TOPIX

11/02/2024 09:30:50 am

Make CT Your Homepage

Merck's Monoclonal Antibody

Merck’s New Therapeutic For Clostridium difficile Infection

Merck’s New Therapeutic For Clostridium Difficile Infection

A study conducted by the international pharmaceutical company Merck discovered an experimental antibody that claims to reduce the recurrence of Clostridium difficile infection by 10%.

Real Time Analytics